ZA200902048B - Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione - Google Patents

Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione

Info

Publication number
ZA200902048B
ZA200902048B ZA200902048A ZA200902048A ZA200902048B ZA 200902048 B ZA200902048 B ZA 200902048B ZA 200902048 A ZA200902048 A ZA 200902048A ZA 200902048 A ZA200902048 A ZA 200902048A ZA 200902048 B ZA200902048 B ZA 200902048B
Authority
ZA
South Africa
Prior art keywords
ione
quinazolin
piperazin
indol
pyrrole
Prior art date
Application number
ZA200902048A
Other languages
English (en)
Inventor
Piotr Karpinski
Stephanie Monnier
Elias Ndzie
Dimitris Papoutsakis
Paul Allen Sutton
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38921707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200902048(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200902048B publication Critical patent/ZA200902048B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200902048A 2006-10-20 2009-03-24 Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione ZA200902048B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85338406P 2006-10-20 2006-10-20

Publications (1)

Publication Number Publication Date
ZA200902048B true ZA200902048B (en) 2010-01-27

Family

ID=38921707

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902048A ZA200902048B (en) 2006-10-20 2009-03-24 Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione

Country Status (23)

Country Link
US (1) US8865897B2 (xx)
EP (1) EP2102195A1 (xx)
JP (1) JP5302199B2 (xx)
KR (1) KR20090073231A (xx)
CN (2) CN101522664B (xx)
AR (1) AR063491A1 (xx)
AU (1) AU2007309558B2 (xx)
BR (1) BRPI0717461A2 (xx)
CA (1) CA2666965A1 (xx)
CL (1) CL2007003006A1 (xx)
EC (1) ECSP099344A (xx)
IL (1) IL197962A (xx)
MA (1) MA30886B1 (xx)
MX (1) MX2009004048A (xx)
MY (1) MY158026A (xx)
NO (1) NO20091970L (xx)
NZ (1) NZ576241A (xx)
PE (1) PE20081133A1 (xx)
RU (1) RU2481341C2 (xx)
TN (1) TN2009000147A1 (xx)
TW (1) TWI399374B (xx)
WO (1) WO2008051440A1 (xx)
ZA (1) ZA200902048B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010520879A (ja) * 2007-03-09 2010-06-17 ノバルティス アーゲー ３−（１ｈ−インドール−３−イル）−４−［２−（４−メチル−ピペラジン−１−イル）−キナゾリン−４−イル］−ピロール−２，５−ジオンの塩
US9017528B2 (en) 2011-04-14 2015-04-28 Tel Nexx, Inc. Electro chemical deposition and replenishment apparatus
US9005409B2 (en) 2011-04-14 2015-04-14 Tel Nexx, Inc. Electro chemical deposition and replenishment apparatus
US9303329B2 (en) 2013-11-11 2016-04-05 Tel Nexx, Inc. Electrochemical deposition apparatus with remote catholyte fluid management

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1337527B1 (en) * 2000-11-07 2009-10-14 Novartis AG Indolylmaleimide derivatives as protein kinase c inhibitors
GB0504203D0 (en) * 2005-03-01 2005-04-06 Novartis Ag Organic compounds
KR20100020478A (ko) 2007-06-18 2010-02-22 사노피-아벤티스 Ｐ2ｙ12 길항제로서의 피롤 유도체

Also Published As

Publication number Publication date
TN2009000147A1 (en) 2010-10-18
AU2007309558A1 (en) 2008-05-02
TW200829572A (en) 2008-07-16
RU2009118816A (ru) 2010-11-27
IL197962A0 (en) 2009-12-24
NZ576241A (en) 2012-05-25
RU2481341C2 (ru) 2013-05-10
MA30886B1 (fr) 2009-11-02
WO2008051440A1 (en) 2008-05-02
CL2007003006A1 (es) 2008-05-23
TWI399374B (zh) 2013-06-21
CN103265533A (zh) 2013-08-28
JP2010506927A (ja) 2010-03-04
KR20090073231A (ko) 2009-07-02
MY158026A (en) 2016-08-30
CN101522664A (zh) 2009-09-02
CN101522664B (zh) 2013-06-12
NO20091970L (no) 2009-05-20
IL197962A (en) 2013-08-29
US20100041884A1 (en) 2010-02-18
PE20081133A1 (es) 2008-09-16
JP5302199B2 (ja) 2013-10-02
MX2009004048A (es) 2009-04-27
US8865897B2 (en) 2014-10-21
BRPI0717461A2 (pt) 2013-10-08
AR063491A1 (es) 2009-01-28
AU2007309558B2 (en) 2012-05-24
ECSP099344A (es) 2009-06-30
EP2102195A1 (en) 2009-09-23
CA2666965A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
HK1090926A1 (en) Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
AU2007261442B2 (en) Adjustable orthotic
EP3150120B8 (de) Orthopädisches interface
SI2049500T1 (sl) Ciklopenta (d) pirimidini kot AKT protein kinazni inhibitorji
EP2162132A4 (en) Heterocyclic kinase modulators
HK1145677A1 (en) Substituted piperidino dihydrothienopyrimidines
EP1862240A4 (en) TIP FOR REPLACING CUTTER EDGE
IL205086A0 (en) Indexable insert
EP2089810A4 (en) SOLICITATION TRANSFORMATIONS FOR RELATIONSHIP OF CONFIDENCE
EP1915575A4 (en) INTRODUCED THERMOMODULE FOR SELF-HEATING TIN
EP2061470A4 (en) HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES
EP1906967A4 (en) ABL Kinase Inhibition
ZA200902048B (en) Crystal modifications-3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-D ione
EP2036893A4 (en) ABL Kinase Inhibitor
IL194388A0 (en) Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma vaccination
GB0405985D0 (en) Kinase
IL183691A0 (en) Biosolids stabilization process
GB0708072D0 (en) Orthotic insole
GB2428195B (en) Patient stability aid
AU2007901022A0 (en) Orthotic insert
TWM300526U (en) Correction insoles
AU2007902932A0 (en) Orthotic Footwear
GB0612600D0 (en) Tiling aids
GB0701525D0 (en) Raised levelling aids
AU2008902799A0 (en) Orthotic Footwear